Place of sulfasalazine in complex treatment of seronegative spondylarthrities

Place of sulfasalazine in complex treatment of seronegative spondylarthrities

Bibliographic Details
Main Author:	V V Badokin
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2004-08-01
Series:	Научно-практическая ревматология
Online Access:	https://rsp.mediar-press.net/rsp/article/view/943

Similar Items

Cardiovascular damage in seronegative spondylarthritis
by: Mihaela STOICA, et al.
Published: (2022-04-01)

Monitoring of subacute Wegener's granulomatosis clinically simulating seronegative spondylarthritis
by: A. A. Muradyants, et al.
Published: (2013-12-01)

Sulfasalazine efficacy and tolerability in rheumatic diseases
by: V. V. Badokin
Published: (2005-08-01)

Role of NOD2 variants in spondylarthritis.
by: Crane, A, et al.
Published: (2002)

MRI Findings in Axial Psoriatic Spondylarthritis
by: Loredana Sabina Pascu, et al.
Published: (2023-04-01)

Variables affecting sulfasalazine - ion exchange resin complexation
by: Ameer Zuhair Wohaib, et al.
Published: (2019-12-01)

Clinical observation of a patient with ankylosing spondylarthritis (Bechterew’s disease)
by: V. V. Tsurko, et al.
Published: (2019-06-01)

EFFECTIVENESS OF INFLIXIMAB IN PATIENTS WITH JUVENILE ANKYLOSING SPONDYLARTHRITIS
by: A.L. Kozlova, et al.
Published: (2009-01-01)

EFFECTIVENESS OF INFLIXIMAB IN PATIENTS WITH JUVENILE ANKYLOSING SPONDYLARTHRITIS
by: A.L. Kozlova, et al.
Published: (2009-03-01)

SULFASALAZINE INDUCED TOXIC HEPATIC INJURY
by: I N Koreneva, et al.
Published: (2002-02-01)

The association of relapsing polychondritis and spondylarthritis – three case reports
by: Eleonora Alina Dragomir-Lica, et al.
Published: (2023-09-01)

Case report: Sulfasalazine-induced hypersensitivity
by: Ekaterina M. Kuchinskaya, et al.
Published: (2023-05-01)

Use of sulfasalazine for psoriasis: An evidence-based review
by: Siddhartha Sood, HBSc, et al.
Published: (2024-06-01)

The place and value of nonsteroidal anti-inflammatory drugs in the therapy of osteoarthritis
by: V. V. Badokin
Published: (2016-03-01)

Sulfasalazine Microparticles Targeting Macrophages for the Treatment of Inflammatory Diseases Affecting the Synovial Cavity
by: Monica-Carolina Villa-Hermosilla, et al.
Published: (2021-06-01)

Sulfasalazine-induced impotence: a beneficial resolution with olsalazine?
by: Ireland, A, et al.
Published: (1989)

Etanercept plus sulfasalazine: added value in rheumatoid arthritis?
by: Fisher, B, et al.
Published: (2007)

Sulfasalazine, but not ankylosing spondylitis may be responsible for axonal neuropathy
by: Josef Finsterer
Published: (2024-01-01)

Sulfasalazine colon-specific drug delivery by selenium nanoparticle
by: Alireza Hashemzadeh, et al.
Published: (2022-12-01)

Inhibiting HLA-B27 homodimer-driven immune cell inflammation in spondylarthritis.
by: Payeli, S, et al.
Published: (2012)

Repurposing Sulfasalazine as a Radiosensitizer in Hypoxic Human Colorectal Cancer
by: Lisa Kerkhove, et al.
Published: (2023-04-01)

Drug-induced nephrolithiasis and crystalluria: the particular case of the sulfasalazine derivatives
by: Chebion, Guillaume, et al.
Published: (2021-09-01)

Role of the Gut Microbiota in Osteoarthritis, Rheumatoid Arthritis, and Spondylarthritis: An Update on the Gut–Joint Axis
by: Umile Giuseppe Longo, et al.
Published: (2024-03-01)

Subclinical Atherosclerosis Measure by Carotid Ultrasound and Inflammatory Activity in Patients with Rheumatoid Arthritis and Spondylarthritis
by: Marta Rojas-Giménez, et al.
Published: (2022-01-01)

Differences of ultrasonographic enthesitis between patients with non-radiographic axial spondylarthritis and ankylosing spondylitis
by: Juan Li, et al.
Published: (2022-11-01)

Colonoscopy aspiration lavages for mucosal metataxonomic profiling of spondylarthritis-associated gastrointestinal tract alterations
by: Ricaurte A. Marquez-Ortiz, et al.
Published: (2023-04-01)

Seronegative autoimmune hepatitis
by: A. O. Buyeverov
Published: (2018-08-01)

Chronic inflammatory bowel damages and seronegative spondyloarthritides
by: V A Voronenko, et al.
Published: (2005-10-01)

Interplay between COVID-19 and Secukinumab treatment in Spondylarthritis patients during the omicron surge: a retrospective cohort study
by: Tong Wu, et al.
Published: (2024-12-01)

Seronegative myasthenia gravis.
by: Vincent, A, et al.
Published: (2004)

The Mayo Clinic-Canadian Cooperative trial of sulfasalazine in active multiple sclerosis.
by: Noseworthy, J, et al.
Published: (1998)

Risk-stratified monitoring for sulfasalazine toxicity: prognostic model development and validation
by: Abhishek Abhishek, et al.
Published: (2024-02-01)

Sulfasalazine antagonizes boosted metastasis of breast cancer induced by ionizing radiation
by: HE Ge, et al.
Published: (2022-09-01)

Why uncritical adherence to recommendations of sulfasalazine leaflet information can lead to medical error in rheumatoid arthritis?
by: Y V Muravyov
Published: (2003-04-01)

A Yoga Exercise App Designed for Patients With Axial Spondylarthritis: Development and User Experience Study
by: Minh Tam Truong, et al.
Published: (2022-06-01)

Validity and feasibility of remote measurement systems for functional movement and posture assessments in people with axial spondylarthritis
by: Erin Hannink, et al.
Published: (2022-12-01)

Evaluation of Sulfasalazine as an Adjunctive Therapy in Treating Pulmonary Pre-XDR-TB: Efficacy, Safety, and Treatment Implication
by: Fu L, et al.
Published: (2024-02-01)

Effect of sulfasalazine on ferroptosis during intestinal injury in rats after liver transplantation
by: Wei Wu, et al.
Published: (2024-03-01)

Immunogram indices in seropositive and seronegative cats for Toxoplasma gondii
by: V. Kusturov, et al.
Published: (2022-07-01)

Pertussis immunity in pregnant women and factors associated with seronegative status
by: E. A. Krieger, et al.
Published: (2021-02-01)